 Twelve-year comparison Bjork-Shiley mechanical heart valve porcine bioprostheses BACKGROUND Patients heart-valve replacement mechanical prosthesis lifelong anticoagulant treatment porcine bioprosthesis absolute need anticoagulants METHODS randomized prospective trial durability Bjork-Shiley mechanical prosthesis spherical tilting-disk model incidence valve-related complications variables Hancock Carpentier-Edwards porcine prostheses mitral valve patients aortic valve survivors mean years RESULTS trend improved actuarial survival years Bjork-Shiley prosthesis trend significant group Bjork-Shiley valve group porcine valve mean SE percent significant difference actuarial incidence reoperation years years patients porcine prosthesis undergone reoperation percent analysis death reoperation end points actuarial assessment survival original prosthesis intact patients Bjork-Shiley Shiley prostheses survival percent years hospitalization blood transfusion frequent patients Bjork-Shiley prostheses percent years significant difference years actuarial occurrence embolism Bjork-Shiley porcine percent endocarditis vs percent CONCLUSIONS Survival intact valve patients Bjork-Shiley spherical tilting-disk prosthesis patients porcine bioprostheses use Bjork-Shiley valve attendant risk need anticoagulant treatment